Our findings suggested that up-regulation of FRα (a putative oncogenic folate transporter) and down-regulation of RFC (a putative tumor suppressor type folate transporter) were controlled genetically and epigenetically respectively during ovarian cancer development. The gene discussed is FOLR1; the disease is neoplasm.